IOL Chemicals and Pharmaceuticals Limited (IOLCP) - Total Assets
Based on the latest financial reports, IOL Chemicals and Pharmaceuticals Limited (IOLCP) holds total assets worth Rs25.87 Billion INR (≈ $279.77 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
IOL Chemicals and Pharmaceuticals Limited - Total Assets Trend (2005–2026)
This chart illustrates how IOL Chemicals and Pharmaceuticals Limited's total assets have evolved over time, based on quarterly financial data. Also see IOL Chemicals and Pharmaceuticals Limite (IOLCP) total market value for the company's overall valuation and market capitalisation.
IOL Chemicals and Pharmaceuticals Limited - Asset Composition Analysis
Current Asset Composition (March 2026)
IOL Chemicals and Pharmaceuticals Limited's total assets of Rs25.87 Billion consist of 47.5% current assets and 52.6% non-current assets. Review IOLCP liabilities breakdown to assess the company's total debt and financial obligations.
| Asset Category | Amount (INR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rs0.00 | 7.7% |
| Accounts Receivable | Rs6.03 Billion | 23.3% |
| Inventory | Rs3.71 Billion | 14.3% |
| Property, Plant & Equipment | Rs0.00 | 0.0% |
| Intangible Assets | Rs147.10 Million | 0.6% |
| Goodwill | Rs0.00 | 0.0% |
Asset Composition Trend (2005–2026)
This chart illustrates how IOL Chemicals and Pharmaceuticals Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See current stock price of IOL Chemicals and Pharmaceuticals Limite for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: IOL Chemicals and Pharmaceuticals Limited's current assets represent 47.5% of total assets in 2026, an increase from 41.7% in 2005.
- Cash Position: Cash and equivalents constituted 7.7% of total assets in 2026, up from 0.3% in 2005.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2005.
- Asset Diversification: The largest asset category is accounts receivable at 23.3% of total assets.
IOL Chemicals and Pharmaceuticals Limited Competitors by Total Assets
Key competitors of IOL Chemicals and Pharmaceuticals Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2
|
Germany | €1.60 Trillion |
|
GALDERMA GROUP AG
NYSE:GALDY
|
USA | $13.39 Billion |
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK
|
USA | $15.42 Trillion |
|
Beijing Tongrentang Co Ltd
SHG:600085
|
China | CN¥31.82 Billion |
|
Takeda Pharmaceutical Company Limited
F:TKDA
|
Germany | €15.41 Trillion |
|
Changchun High & New Technology Industries Group Inc
SHE:000661
|
China | CN¥30.77 Billion |
|
Neuland Laboratories Limited
NSE:NEULANDLAB
|
India | Rs29.30 Billion |
|
China Resources Double-Crane Pharmaceutical Co Ltd
SHG:600062
|
China | CN¥17.01 Billion |
IOL Chemicals and Pharmaceuticals Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.78 | 1.89 | 3.52 |
| Quick Ratio | 1.24 | 1.30 | 2.50 |
| Cash Ratio | 0.00 | 0.34 | 0.00 |
| Working Capital | Rs5.37 Billion | Rs5.41 Billion | Rs7.32 Billion |
IOL Chemicals and Pharmaceuticals Limited - Advanced Valuation Insights
This section examines the relationship between IOL Chemicals and Pharmaceuticals Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.69 |
| Latest Market Cap to Assets Ratio | 0.02 |
| Asset Growth Rate (YoY) | 8.6% |
| Total Assets | Rs25.87 Billion |
| Market Capitalization | $569.87 Million USD |
Valuation Analysis
Below Book Valuation: The market values IOL Chemicals and Pharmaceuticals Limited's assets below their book value (0.02x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: IOL Chemicals and Pharmaceuticals Limited's assets grew by 8.6% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for IOL Chemicals and Pharmaceuticals Limited (2005–2026)
The table below shows the annual total assets of IOL Chemicals and Pharmaceuticals Limited from 2005 to 2026.
| Year | Total Assets | Change |
|---|---|---|
| 2026-03-31 | Rs25.87 Billion ≈ $279.77 Million |
+8.60% |
| 2025-03-31 | Rs23.82 Billion ≈ $257.61 Million |
+6.13% |
| 2024-03-31 | Rs22.44 Billion ≈ $242.72 Million |
+10.99% |
| 2023-03-31 | Rs20.22 Billion ≈ $218.69 Million |
+3.05% |
| 2022-03-31 | Rs19.62 Billion ≈ $212.22 Million |
+21.88% |
| 2021-03-31 | Rs16.10 Billion ≈ $174.13 Million |
+37.64% |
| 2020-03-31 | Rs11.70 Billion ≈ $126.51 Million |
+24.20% |
| 2019-03-31 | Rs9.42 Billion ≈ $101.86 Million |
+10.54% |
| 2018-03-31 | Rs8.52 Billion ≈ $92.15 Million |
+4.23% |
| 2017-03-31 | Rs8.17 Billion ≈ $88.41 Million |
+5.36% |
| 2016-03-31 | Rs7.76 Billion ≈ $83.91 Million |
+10.58% |
| 2015-03-31 | Rs7.02 Billion ≈ $75.88 Million |
-5.33% |
| 2014-03-31 | Rs7.41 Billion ≈ $80.15 Million |
+1.95% |
| 2013-03-31 | Rs7.27 Billion ≈ $78.62 Million |
+5.82% |
| 2012-03-31 | Rs6.87 Billion ≈ $74.29 Million |
+12.64% |
| 2011-03-31 | Rs6.10 Billion ≈ $65.95 Million |
+20.00% |
| 2010-03-31 | Rs5.08 Billion ≈ $54.96 Million |
+21.08% |
| 2009-03-31 | Rs4.20 Billion ≈ $45.39 Million |
+73.96% |
| 2008-03-31 | Rs2.41 Billion ≈ $26.09 Million |
+36.49% |
| 2007-03-31 | Rs1.77 Billion ≈ $19.12 Million |
+86.77% |
| 2006-03-31 | Rs946.52 Million ≈ $10.24 Million |
+57.54% |
| 2005-03-31 | Rs600.82 Million ≈ $6.50 Million |
-- |
About IOL Chemicals and Pharmaceuticals Limited
IOL Chemicals and Pharmaceuticals Limited manufactures and sells pharmaceutical and chemical products in India and internationally. The company operates through, Chemical and Pharmaceutical segments. The Chemical segment offers ethyl acetate, iso butyl benzene, acetyl chloride, mono chloro acetic acid, and acetic anhydride to food processing, flexible packaging, pharmaceuticals, textiles, ink, pa… Read more